286 related articles for article (PubMed ID: 8524848)
1. A role for Rho in Ras transformation.
Qiu RG; Chen J; McCormick F; Symons M
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11781-5. PubMed ID: 8524848
[TBL] [Abstract][Full Text] [Related]
2. Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation.
Qiu RG; Abo A; McCormick F; Symons M
Mol Cell Biol; 1997 Jun; 17(6):3449-58. PubMed ID: 9154844
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation.
Izawa I; Amano M; Chihara K; Yamamoto T; Kaibuchi K
Oncogene; 1998 Dec; 17(22):2863-71. PubMed ID: 9879992
[TBL] [Abstract][Full Text] [Related]
4. An essential role for Rac in Ras transformation.
Qiu RG; Chen J; Kirn D; McCormick F; Symons M
Nature; 1995 Mar; 374(6521):457-9. PubMed ID: 7700355
[TBL] [Abstract][Full Text] [Related]
5. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
6. Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts.
Tang Y; Yu J; Field J
Mol Cell Biol; 1999 Mar; 19(3):1881-91. PubMed ID: 10022875
[TBL] [Abstract][Full Text] [Related]
7. Mas oncogene signaling and transformation require the small GTP-binding protein Rac.
Zohn IE; Symons M; Chrzanowska-Wodnicka M; Westwick JK; Der CJ
Mol Cell Biol; 1998 Mar; 18(3):1225-35. PubMed ID: 9488437
[TBL] [Abstract][Full Text] [Related]
8. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.
Khosravi-Far R; Solski PA; Clark GJ; Kinch MS; Der CJ
Mol Cell Biol; 1995 Nov; 15(11):6443-53. PubMed ID: 7565796
[TBL] [Abstract][Full Text] [Related]
9. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
10. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.
Lebowitz PF; Davide JP; Prendergast GC
Mol Cell Biol; 1995 Dec; 15(12):6613-22. PubMed ID: 8524226
[TBL] [Abstract][Full Text] [Related]
11. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
12. G2A is an oncogenic G protein-coupled receptor.
Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N; Crespo P; Bustelo XR
Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
[TBL] [Abstract][Full Text] [Related]
14. Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes.
Teramoto H; Malek RL; Behbahani B; Castellone MD; Lee NH; Gutkind JS
Oncogene; 2003 May; 22(17):2689-97. PubMed ID: 12730683
[TBL] [Abstract][Full Text] [Related]
15. Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA.
Chang YW; Putzer K; Ren L; Kaboord B; Chance TW; Qoronfleh MW; Jakobi R
J Cell Biochem; 2005 Oct; 96(2):314-29. PubMed ID: 16088958
[TBL] [Abstract][Full Text] [Related]
17. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
Zohn IM; Campbell SL; Khosravi-Far R; Rossman KL; Der CJ
Oncogene; 1998 Sep; 17(11 Reviews):1415-38. PubMed ID: 9779988
[TBL] [Abstract][Full Text] [Related]
18. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
19. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line.
Ghosh PM; Ghosh-Choudhury N; Moyer ML; Mott GE; Thomas CA; Foster BA; Greenberg NM; Kreisberg JI
Oncogene; 1999 Jul; 18(28):4120-30. PubMed ID: 10435593
[TBL] [Abstract][Full Text] [Related]
20. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
